Filana Therapeutics (FLNA) Earnings Analysis
Filana Therapeutics (FLNA) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -0.21 USD vs -0.23 USD est (+8.7%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -0.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does FLNA next report earnings?
No confirmed upcoming earnings date is currently scheduled for FLNA. This page updates as the calendar is published.
FLNA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.21 USD | -0.23 USD | +8.7% | Beat |
| 2026-03-12 | -0.26 USD | -0.3 USD | +13.3% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
FLNA valuation and analyst view
| Trailing P/E | -0.60 |
|---|---|
| Trailing EPS | -1.61259 USD |
| Price / book | 0.68 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Filana Therapeutics (FLNA)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for FLNA. This page updates as the calendar is published.
Did FLNA beat earnings last quarter?
In its 2026-05-07 report, FLNA posted EPS of -0.21 USD versus a -0.23 USD estimate — a beat of 8.7%.
What is FLNA's earnings track record?
Over the last 2 reported quarters with consensus data, FLNA beat estimates 2 times (100%).
What is FLNA's current P/E ratio and EPS?
FLNA trades at a trailing P/E of -0.60 on trailing EPS of -1.6125900471971517 USD.
What do analysts rate FLNA?
FLNA has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.